U.S. Food Stock News

NasdaqGS:SEDG
NasdaqGS:SEDGSemiconductor

SolarEdge Technologies (SEDG) Q1 Loss Narrows Yet Leaves Margin Recovery Narrative Unproven

Q1 2026 results in focus SolarEdge Technologies (SEDG) opened 2026 with Q1 revenue of US$310.5 million and a basic EPS loss of US$0.94, alongside trailing twelve month revenue of US$1.28 billion and a basic EPS loss of US$5.99. Over recent quarters the company has seen revenue move from US$196.2 million in Q4 2024 to between roughly US$219.5 million and US$340.2 million through 2025. Over the same period, quarterly basic EPS has ranged from a loss of US$0.84 to a loss of US$5.00, setting up...
NasdaqGM:IESC
NasdaqGM:IESCConstruction

Is It Too Late To Consider IES Holdings (IESC) After Its Recent Share Price Surge?

If you are wondering whether IES Holdings at around US$673.84 is still reasonably priced after its strong run, this breakdown will help you frame what that sticker price might actually represent. The stock has seen very strong recent returns, with about 17.8% over the last week, 37.8% over the past month, 65.6% year to date and 178.9% over the last year, plus a very large gain over three years that is more than 7x and a similarly very large gain over five years. These moves have put IES...
NasdaqGS:FTRE
NasdaqGS:FTRELife Sciences

Is It Too Late To Consider Fortrea Holdings (FTRE) After Its Recent Share Price Surge?

If you are wondering whether Fortrea Holdings at US$15.64 is still offering value after a strong run, or if you are late to the story, this article focuses on what the current price might be implying. The stock has moved sharply, with returns of 48.1% over the last 7 days, 73.6% over the last 30 days and 177.8% over the last year, although year to date it sits at a 7.0% decline. Recent market attention has centered on Fortrea's position within the life sciences and pharmaceutical services...
NYSE:CW
NYSE:CWAerospace & Defense

Is It Too Late To Consider Curtiss-Wright (CW) After A 105% One-Year Rally?

Investors may be wondering whether Curtiss-Wright still offers good value after a strong share price performance, or if the current price has moved ahead of what the underlying business might justify. The stock last closed at US$742.89, with returns of 6.7% over 7 days, 6.3% over 30 days, 29.8% year to date and 105.5% over 1 year. These figures naturally raise questions about how much of the company’s story may already be reflected in the price. Recent attention on Curtiss-Wright has...
NasdaqGS:ICHR
NasdaqGS:ICHRSemiconductor

Ichor Holdings (ICHR) Q1 Loss Per Share Narrows Challenging Bearish Earnings Narratives

Ichor Holdings (ICHR) opened Q1 2026 with revenue of US$256.1 million and a basic EPS loss of US$0.07, alongside a trailing 12 month basic EPS loss of US$1.47 on revenue of US$959.3 million. Over recent quarters, the company has seen revenue move from US$244.5 million and a basic EPS loss of US$0.13 in Q1 2025 to US$223.6 million with a basic EPS loss of US$0.46 in Q4 2025, setting up this latest print as part of a wider stretch of loss making results. For investors, the key question now is...
NasdaqGM:SITM
NasdaqGM:SITMSemiconductor

SiTime (SITM) Is Up 18.2% After AI-Fueled Q1 Beat And Raised Outlook Has The Bull Case Changed?

SiTime Corporation recently reported first-quarter 2026 results, with sales rising to US$113.57 million from US$60.31 million a year earlier and net loss narrowing to US$5.22 million, alongside a strong uplift in adjusted earnings and an upbeat full-year revenue growth outlook. Management linked this performance to accelerating demand from AI data centers and highlighted momentum in higher-value Precision Timing products as a core driver. Now we’ll examine how this AI-driven revenue...
NasdaqGS:MMSI
NasdaqGS:MMSIMedical Equipment

FDA Recall Puts Merit Medical Quality Controls And Growth Story In Focus

Arrow International issued a nationwide recall of certain dialysis catheter kits that include Merit Medical’s 16F Dual-Valved Splittable Sheath Introducers. The recall is linked to a design defect that may prevent the sheath from splitting as intended during use. The action centers on product quality and regulatory compliance risks that could affect NasdaqGS:MMSI. Merit Medical Systems (NasdaqGS:MMSI) supplies devices used across interventional cardiology, radiology, and vascular access,...
NasdaqGS:CHYM
NasdaqGS:CHYMDiversified Financial

3 Growth Stocks Insiders Are Betting On

Over the last 7 days, the United States market has risen by 3.2%, contributing to a remarkable 31% increase over the past year, with earnings forecasted to grow by 16% annually. In this thriving environment, growth companies with high insider ownership often attract attention as they suggest confidence from those closest to the business and potential for sustained performance.
NYSE:RSKD
NYSE:RSKDSoftware

Cricut And 2 Other Penny Stocks With Promising Potential

Over the last 7 days, the United States market has risen 3.2%, and over the past year, it has climbed an impressive 31%, with earnings forecasted to grow by 16% annually. In such a robust market environment, identifying stocks with strong financials can be key to capturing growth potential. Although the term "penny stocks" might seem outdated, these investments in smaller or newer companies continue to offer intriguing opportunities for those seeking affordability and potential growth.
NasdaqGS:CFFN
NasdaqGS:CFFNBanks

Discovering US Market's Undiscovered Gems in May 2026

Over the last 7 days, the United States market has risen by 3.2% and is up 31% over the last year, with earnings forecast to grow by 16% annually. In this thriving environment, identifying stocks that are not only poised for growth but also remain underappreciated can offer unique opportunities for investors seeking undiscovered gems.
NasdaqGS:INDB
NasdaqGS:INDBBanks

Dividend Stocks To Consider In May 2026

The United States market has experienced a robust performance recently, climbing 3.2% in the last week and rising 31% over the past year, with earnings projected to grow by 16% annually. In this thriving environment, dividend stocks can be an attractive option for investors seeking steady income and potential growth, as they offer regular payouts while benefiting from the overall market's upward momentum.
NYSE:ANF
NYSE:ANFSpecialty Retail

Is It Time To Reassess Abercrombie & Fitch (ANF) After The Recent Share Price Pullback

For investors wondering if Abercrombie & Fitch is still good value after its recent run and subsequent pullbacks, this piece breaks down what the current share price might be implying about the stock. The stock last closed at US$79.40, with returns of 14.0% over the past year. Shorter-term moves include a 5.6% decline over 7 days, an 18.5% decline over 30 days, and a 35.8% decline year to date. Recent price action has put extra attention on whether earlier gains are fully justified or if the...
NYSE:GHC
NYSE:GHCConsumer Services

Assessing Graham Holdings (GHC) Valuation After Q1 2026 Results And Share Buyback Completion

Q1 performance and capital returns in focus Graham Holdings (GHC) has come onto investors’ radar after reporting Q1 2026 results alongside an update on its ongoing share repurchase, putting both business performance and capital return activity in focus. For the quarter ended March 31, 2026, the company reported revenue of US$1,235.99 million and net income of US$29.11 million. Over the same period, it continued buying back stock, completing the repurchase of 69,708 shares for US$64.89 million...
NasdaqGS:NMRK
NasdaqGS:NMRKReal Estate

Is It Too Late To Consider Newmark Group (NMRK) After Its Strong Recent Share Price Run?

Investors may be wondering if Newmark Group at around US$16.60 is still offering value after a strong run, or if most of the upside is already reflected in the price. The stock has returned 5.3% over the past week and 13.2% over the past month, while the 1 year return sits at 49.7% and the 3 year return is a very large multiple, with a 5 year return of 36.3%. This means recent moves come on top of a sizeable longer term track record. Recent coverage around Newmark Group has focused on its...
NYSE:CBRE
NYSE:CBREReal Estate

Is CBRE’s Earnings Beat and Capital Moves Altering The Investment Case For CBRE Group (CBRE)?

In late April 2026, CBRE Group reported first-quarter 2026 results showing higher sales and net income than a year earlier, completed a long-running share buyback program totaling US$4.73 billion, and priced a US$750 million senior notes offering mainly to repay commercial paper borrowings. Together, these moves highlight CBRE’s focus on strengthening its balance sheet while returning capital to shareholders, underpinned by growing contributions from infrastructure and outsourcing-related...
NYSE:WM
NYSE:WMCommercial Services

Is Waste Management (WM) Fairly Priced After Recent Share Price Weakness?

Wondering whether Waste Management's current share price reflects its true value, or if you might be paying too much for a steady, essential service stock. The stock recently closed at US$220.52, with returns of a 4.3% decline over 7 days, a 5.7% decline over 30 days, a 1.0% gain year to date, and a 4.9% decline over the past year. The 3 year and 5 year returns stand at 35.4% and 72.5% respectively. Recent coverage has focused on Waste Management's position as a core provider in the...
NYSE:ALK
NYSE:ALKAirlines

Alaska Air Group (ALK) Valuation Check As New Bond Issue Reshapes Funding And Growth Expectations

Why Alaska Air Group Just Tapped the Bond Market Alaska Air Group (ALK) has launched a US$500 million senior unsecured notes offering due 2031, a move that puts its balance sheet decisions and funding mix in clearer focus for stock and bond investors. See our latest analysis for Alaska Air Group. The bond announcement came alongside a short term rebound in the stock, with a 1 day share price return of 5.19% and a 7 day gain of 5.74%. However, the 1 year total shareholder return of 19.24% and...
NasdaqGS:SOLS
NasdaqGS:SOLSChemicals

Solstice Advanced Materials (SOLS) Is Up 6.6% After Mixed Q1 Earnings and Dividend Reaffirmation - What's Changed

Solstice Advanced Materials reported first-quarter 2026 results with net sales rising to US$991 million from US$897 million a year earlier, while net income declined to US$85 million from US$134 million, and the board affirmed a quarterly dividend of US$0.075 per share payable on June 10, 2026. The results highlight how Solstice’s role across AI cooling, nuclear fuel conversion, and semiconductor materials is becoming increasingly central even as reported earnings lag top-line...
NasdaqGS:SFD
NasdaqGS:SFDFood

Smithfield Foods Faces Rising Scrutiny On Chinese Ties And Farmland Risk

U.S. authorities are increasing scrutiny of Smithfield Foods' foreign ownership ties, focusing on its Chinese parent and U.S. farmland holdings. National security reviews are expanding to foreign-owned agricultural land, especially near sensitive sites, putting Smithfield Foods' property footprint under closer review. These developments introduce fresh policy and perception risks for Smithfield Foods, which have not been reflected in earlier coverage. For investors tracking NasdaqGS:SFD,...
NasdaqGS:ACAD
NasdaqGS:ACADBiotechs

Is ACADIA Pharmaceuticals (ACAD) Offering Value After A 45% One Year Share Price Gain?

If you are trying to work out whether ACADIA Pharmaceuticals at around US$21.48 is attractively priced or not, the key question is what you are really getting for that price. The stock is currently around 18.3% lower year to date, yet it has returned 45.0% over the last year, a mix that can change how the market is thinking about both potential and risk. Recent news flow around ACADIA Pharmaceuticals has largely focused on its position in the pharmaceuticals and biotech space and how...
NYSE:MCK
NYSE:MCKHealthcare

McKesson’s New US$5b Credit Facility Reshapes Liquidity And Leverage Options

McKesson (NYSE:MCK) has entered into a new multi currency revolving credit agreement totaling US$5b. The facility replaces the company’s prior revolving credit arrangements and is scheduled to mature in April 2031. The agreement expands McKesson’s available committed liquidity and extends the duration of its bank credit support. McKesson is a major distributor of pharmaceuticals and medical supplies, so access to committed bank funding can be important when working with large inventories...
NYSE:ENR
NYSE:ENRHousehold Products

A Look At Energizer Holdings (ENR) Valuation After Q2 Earnings Beat And Raised Full Year Guidance

Energizer Holdings (ENR) just posted mixed Q2 results, with earnings beating forecasts while net sales declined year over year, and management raising full year guidance to the high end of prior ranges. See our latest analysis for Energizer Holdings. The earnings beat, tariff refund benefits and raised guidance have helped the share price rebound, with a 12.51% 30 day share price return and 6.27% gain in the last session. However, the 1 year total shareholder return of 8.73% and 5 year total...
NYSE:IFF
NYSE:IFFChemicals

IFF (IFF) Earnings Return To Profit Challenges Bearish Margin Narratives

International Flavors & Fragrances (IFF) opened 2026 with Q1 revenue of US$2,741 million and basic EPS of US$0.66, setting a cleaner earnings picture after a volatile run of prior quarters. The company has seen quarterly revenue move from US$2,843 million and basic EPS of a US$3.98 loss in Q1 2025 to US$2,741 million and basic EPS of US$0.66 in Q1 2026. The trailing twelve month basic EPS is US$3.23 on revenue of US$10.8b. For investors, the key takeaway is that margins now look more...